| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/08/2006 | EP1631305A2 Sincalide formulations |
| 03/08/2006 | EP1631299A2 Methods and compositions to treat myocardial conditions |
| 03/08/2006 | EP1631268A2 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 03/08/2006 | EP1265990B1 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 03/08/2006 | EP1210068B1 Use of simple amino acids to form porous particles |
| 03/08/2006 | EP1003774B1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 03/08/2006 | CN1744921A Ultrasound contrast agents and process for the preparation thereof |
| 03/08/2006 | CN1744920A Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 03/08/2006 | CN1744906A Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 03/08/2006 | CN1744893A Method for treating ischemic stroke with melatonin |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008625 Recombinant constructs of Borrelia burgdorferi |
| 03/07/2006 | US7008614 For selectively accumulating an iodine compound in a lesion of a vascular disease caused by abnormal proliferation of vascular smooth muscle cells such as arteriosclerosis and restenosis |
| 03/07/2006 | US7008613 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 03/07/2006 | US7008433 Vertebroplasty injection device |
| 03/02/2006 | WO2006023658A2 Method of pre-selecting patients for anti-vegf, anti-hif-1 or anti-thioredoxin therapy |
| 03/02/2006 | WO2006023581A2 Quantitative single image-based magnetization transfer weighted imaging using an inter-subject normalization reference within the image |
| 03/02/2006 | WO2006023200A2 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 03/02/2006 | WO2006022754A2 Radiopaque polymeric stents |
| 03/02/2006 | WO2005122891A8 Lipophilic derivatives of chelate monoamides |
| 03/02/2006 | WO2005107387A3 Targeting of radioimagining and radiotherapy agents |
| 03/02/2006 | WO2005063304A3 Poly (l-glutamic acid) paramagnetic material complex and use as a biodegradable mri contrast agent |
| 03/02/2006 | WO2005045032A3 RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/02/2006 | WO2004069169A3 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 03/02/2006 | US20060045847 Method for determination of anabolic activity |
| 03/02/2006 | DE19916896B4 Teilchen mit kleiner Dimension, die eine Wand aus einem Gemisch von vernetzten Proteinen und Polysacchariden aufweisen, die an der Oberfläche mit Metallionen chelatbildende Hydroxamgruppen enthalten, Verfahren zu ihrer Herstellung und ihre verschiedenen Verwendungen insbesondere in der kosmetischen, pharmazeutischen und Nahrungsmittelindustrie Particles having smaller dimensions, which have a wall composed of a mixture of cross-linked proteins, and polysaccharides containing on the surface with metal ions chelating hydroxamic groups, process for their preparation and to their different uses, particularly in the cosmetic, pharmaceutical and food industry |
| 03/02/2006 | DE102004023093B3 Trimere makrocyclisch substituierte Halogen-Benzolderivate Trimeric macrocyclic substituted halogen-benzene derivatives |
| 03/02/2006 | CA2647021A1 Radiopaque polymeric stents |
| 03/02/2006 | CA2578217A1 Improved selection of ph-dependent compounds for in vivo therapy |
| 03/02/2006 | CA2577312A1 Method of pre-selecting patients for anti-vegf, anti hif-1 or anti-thioredoxin therapy |
| 03/02/2006 | CA2573453A1 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 03/01/2006 | EP1629281A2 Diagnostic method for atherosclerosis |
| 03/01/2006 | EP1629105A2 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells |
| 03/01/2006 | EP1628687A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 03/01/2006 | EP1628577A2 Ultrasound coupling medium for use in medical diagnostics |
| 03/01/2006 | EP1456375B1 Screening methods employing fish model assessment of vision |
| 03/01/2006 | EP1127355B1 Products and methods for brachytherapy |
| 03/01/2006 | EP0973552B1 Improvements in or relating to diagnostic/therapeutic agents |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | CN1739806A Acoustical contrast medium of polymer material and its prepn |
| 03/01/2006 | CN1739521A Application of pyrimidone compounds in preparing medicine |
| 03/01/2006 | CN1243518C Patch for screening sensitivity state of subject with respect to allergen and use thereof |
| 03/01/2006 | CN1243516C Wrinkle indicator tape strip and method of using the same |
| 02/28/2006 | US7005517 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005297 Use of neuroactive compounds |
| 02/28/2006 | US7005120 Osmotically stabilized microbubble preparations |
| 02/28/2006 | CA2515158A1 Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease |
| 02/23/2006 | WO2006020156A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease |
| 02/23/2006 | WO2005093422A3 Carbohydrate-encapsulated quantum dots for biological imaging |
| 02/23/2006 | WO2005057222A3 Use of t-cadherin as a target |
| 02/23/2006 | WO2005045040A3 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID /siNA) |
| 02/23/2006 | US20060041105 Peptides whose uptake by cells is controllable |
| 02/23/2006 | US20060040959 Adenosine A3 receptor modulators |
| 02/23/2006 | US20060040324 Methods for making metallopeptides and metallopeptide libraries |
| 02/23/2006 | US20060040254 Evaluate drugs capable of inhibiting the vanilloid receptor; establish a relaxed bronchial base line state; expose tissue to a dose of a contraction effective agent causing first tensioned state; expose tissue to the candidate substance; allow to return to a base line state |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | US20060039865 Pharmaceutical compositions and methods for the prevention of drug misuse |
| 02/23/2006 | US20060039863 Use of cyanine dyes for the diagnosis of disease associated with angiogenesis |
| 02/23/2006 | US20060039862 Identification and use of growth hormone secretagogue receptor type 1A antagonists |
| 02/23/2006 | US20060039861 For magnetic resonance imaging (MRI); peptide modified at its N- and its C-termini, independently, with a moiety comprising a metal chelate complex; specific binding affinity for fibrin; sufficient half-life in vivo |
| 02/23/2006 | US20060039856 Magnetic resonance with stimulation |
| 02/23/2006 | CA2577620A1 Method of detecting and treating allogenic cells responsible for endometriosis |
| 02/23/2006 | CA2575677A1 Gas-filled microvesicles composition for contrast imaging |
| 02/23/2006 | CA2575163A1 Adenoviral vector compositions |
| 02/23/2006 | CA2573819A1 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
| 02/22/2006 | EP1627395A2 Ferrofluids stable in neutral media and modified ferrofluids modifies obtained by modification of the surface of the particles of said ferrofluids |
| 02/22/2006 | EP1626650A2 Methods and probes for identifying vulnerable plaque |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | CN1739028A Antibody or neutrophil-mediated ozone generation |
| 02/22/2006 | CN1738815A 整联蛋白靶向的影像剂 Integrin targeting imaging agent |
| 02/22/2006 | CN1738651A Contrast media formulations having improved biological tolerance |
| 02/22/2006 | CN1738650A 改进的胃泌素释放肽化合物 Improved gastrin-releasing peptide compounds |
| 02/22/2006 | CN1738649A Imaging infection using fluorescent protein as a marker |
| 02/21/2006 | US7001602 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 02/21/2006 | US7001598 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 02/21/2006 | US7001587 Administering labeled water to individual over time for label to be incorporated into proteins or peptides, obtaining body tissues or fluids from individual, detecting incorporation of label in proteins or peptides to determine biosynthetic rate |
| 02/21/2006 | US7001340 Assessment of concentration of inhalational compounds in the brain |
| 02/21/2006 | US7001339 Filling lungs with gas; measurement, calibration; anesthetic in brain |
| 02/16/2006 | WO2006017812A1 Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents |
| 02/16/2006 | WO2006017336A2 Ceramic structures for prevention of drug diversion |
| 02/16/2006 | WO2006017293A2 Models and methods for nociception, pain transduction, and screening for analgesic compounds |
| 02/16/2006 | WO2006016468A1 Method of producing liposome-containing preparation |
| 02/16/2006 | WO2006015976A1 Diagnostic and therapeutic use of a plasma membrane atpase |
| 02/16/2006 | WO2005082423A3 Serum albumin conjugated to fluorescent substances for imaging |
| 02/16/2006 | WO2005079391A3 Contrast agents for myocardial perfusion imaging |
| 02/16/2006 | WO2005013897A3 Magnetic nanoparticle compositions, and methods related thereto |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060036165 Tissue site markers for in vivo imaging |
| 02/16/2006 | US20060036159 Biopsy cavity marking device |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060034774 Galactopyrannosyltriaminetetracarboxylate as ligands for bioactivated paramagnetic metal complexes |
| 02/16/2006 | US20060034773 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/16/2006 | US20060034772 Composition comprising low density microspheres |
| 02/16/2006 | US20060034771 Ultrasound contrast agents and methods of making and using them |
| 02/16/2006 | US20060034770 Ultrasound contrast agents and process for the preparation thereof |
| 02/16/2006 | US20060034769 Radiopaque polymeric stents |
| 02/16/2006 | US20060034768 Method and device for molecular imaging with the aid of molecular probe |
| 02/16/2006 | US20060034767 Targeting and tracking of cells to specific organs and tissues in vivo |